procyanidin b2-3,3'-di-o-gallate and Angiogenesis, Pathologic

procyanidin b2-3,3'-di-o-gallate has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, C; Agarwal, R; Deep, G; Kumar, R; Wempe, MF	1

Other Studies

1 other study(ies) available for procyanidin b2-3,3'-di-o-gallate and Angiogenesis, Pathologic

Article	Year
Procyanidin B2 3,3″-di-O-gallate inhibits endothelial cells growth and motility by targeting VEGFR2 and integrin signaling pathways. Current cancer drug targets, 2015, Volume: 15, Issue:1 Topics: Anthocyanins; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunoblotting; Integrins; Male; Neovascularization, Pathologic; Prostate; Prostatic Neoplasms; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2	2015

Article

Year

Procyanidin B2 3,3″-di-O-gallate inhibits endothelial cells growth and motility by targeting VEGFR2 and integrin signaling pathways.

Current cancer drug targets, 2015, Volume: 15, Issue:1

Topics: Anthocyanins; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunoblotting; Integrins; Male; Neovascularization, Pathologic; Prostate; Prostatic Neoplasms; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2

2015